The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of lisaftoclax (APG-2575), a novel BCL-2 inhibitor (BCL-2i), in patients (pts) with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (R/R CLL/SLL).
 
Jianyong Li
No Relationships to Disclose
 
Keshu Zhou
No Relationships to Disclose
 
Weiqi Nian
No Relationships to Disclose
 
Guohui Cui
No Relationships to Disclose
 
Jishi Wang
No Relationships to Disclose
 
Xiaoping Zhang
No Relationships to Disclose
 
Hong Cen
No Relationships to Disclose
 
Fei Li
No Relationships to Disclose
 
Shuhua Yi
No Relationships to Disclose
 
Ru Feng
No Relationships to Disclose
 
Chongyuan Xu
No Relationships to Disclose
 
Wenbin Qian
No Relationships to Disclose
 
Lihong Liu
No Relationships to Disclose
 
Caixia Li
No Relationships to Disclose
 
Xielan Zhao
No Relationships to Disclose
 
Zi Chen
No Relationships to Disclose
 
Junxiao Qiao
Employment - Ascentage Pharma
Leadership - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
Honoraria - Ascentage Pharma
Travel, Accommodations, Expenses - Ascentage Pharma
 
Hongli Zhang
Employment - Ascentage Pharma Group
Stock and Other Ownership Interests - Ascentage Pharma Group
Research Funding - Ascentage Pharma Group (Inst)
 
Mohammad Ahmad
Employment - Ascentage Pharma Group
 
Yifan Zhai
Employment - Ascentage Pharma Group; Ascentage Pharma Group (I)
Leadership - Ascentage Pharma Group; Ascentage Pharma Group (I)
Stock and Other Ownership Interests - Ascentage Pharma Group; Ascentage Pharma Group (I)
Research Funding - Ascentage Pharma Group (Inst)
Patents, Royalties, Other Intellectual Property - Ascentage Pharma Group; Ascentage Pharma Group (I); Ascentage Pharma Group (Inst)